254 related articles for article (PubMed ID: 8304226)
1. Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein.
Westerhof GR; Schornagel JH; Rijnboutt S; Pinedo HM; Jansen G
Adv Exp Med Biol; 1993; 338():771-4. PubMed ID: 8304226
[No Abstract] [Full Text] [Related]
2. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
[TBL] [Abstract][Full Text] [Related]
3. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
4. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
Yang CH; Sirotnak FM; Mines LS
J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
[TBL] [Abstract][Full Text] [Related]
5. The reduced folate/methotrexate carrier and a membrane-associated folate binding protein as transport routes for novel antifolates: structure-activity relationships.
Jansen G; Westerhof GR; Schornagel JH; Jackman AL; Boyle FT
Adv Exp Med Biol; 1993; 338():767-70. PubMed ID: 8304225
[No Abstract] [Full Text] [Related]
6. Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells.
Dixon KH; Mulligan T; Chung KN; Elwood PC; Cowan KH
J Biol Chem; 1992 Nov; 267(33):24140-7. PubMed ID: 1429743
[TBL] [Abstract][Full Text] [Related]
7. Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF).
Pavlovic M; Leffert JJ; Russello O; Bunni MA; Beardsley GP; Priest DG; Pizzorno G
Adv Exp Med Biol; 1993; 338():775-8. PubMed ID: 8304227
[No Abstract] [Full Text] [Related]
8. Determinants of the disparate antitumor effects of (6R)5,10-dideaza-5,6,7,8- tetrahydrofolate and methotrexate toward methotrexate resistant CCRF-CEM cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM
Adv Exp Med Biol; 1993; 338():783-6. PubMed ID: 8304229
[No Abstract] [Full Text] [Related]
9. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
[TBL] [Abstract][Full Text] [Related]
10. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates.
Wang X; Shen F; Freisheim JH; Gentry LE; Ratnam M
Biochem Pharmacol; 1992 Nov; 44(9):1898-901. PubMed ID: 1449544
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake.
van der Veer LJ; Westerhof GR; Rijksen G; Schornagel JH; Jansen G
Leuk Res; 1989; 13(11):981-7. PubMed ID: 2532692
[TBL] [Abstract][Full Text] [Related]
12. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
Sirotnak FM; Donsbach RC
Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
[No Abstract] [Full Text] [Related]
13. Suramin sodium: pronounced effects on methotrexate transport and anti-folate activity in cultured tumor cells.
Rideout DC; Bustamante A; Patel R; Henderson GB
Int J Cancer; 1995 Jun; 61(6):840-7. PubMed ID: 7790120
[TBL] [Abstract][Full Text] [Related]
14. Role of the membrane-associated folate binding protein (folate receptor) in methotrexate transport by human KB cells.
Deutsch JC; Elwood PC; Portillo RM; Macey MG; Kolhouse JF
Arch Biochem Biophys; 1989 Nov; 274(2):327-37. PubMed ID: 2552922
[TBL] [Abstract][Full Text] [Related]
15. Folate coenzyme and antifolate transport proteins in normal and neoplastic cells.
Freisheim JH; Price EM; Ratnam M
Adv Enzyme Regul; 1989; 29():13-26. PubMed ID: 2561247
[TBL] [Abstract][Full Text] [Related]
16. Number of binding sites and possible mechanisms of action.
Condit PT
Ann N Y Acad Sci; 1971 Nov; 186():363-4. PubMed ID: 4943807
[No Abstract] [Full Text] [Related]
17. Variable pharmacodynamics of antifolates in squamous cell carcinoma of the head and neck.
Braakhuis BJ; Jansen G; Peters GJ
Adv Exp Med Biol; 1993; 338():671-4. PubMed ID: 8304205
[No Abstract] [Full Text] [Related]
18. Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.
Theti DS; Bavetsias V; Skelton LA; Titley J; Gibbs D; Jansen G; Jackman AL
Cancer Res; 2003 Jul; 63(13):3612-8. PubMed ID: 12839949
[TBL] [Abstract][Full Text] [Related]
19. The influence of extracellular folate concentration on methotrexate uptake by human KB cells. Partial characterization of a membrane-associated methotrexate binding protein.
Kane MA; Portillo RM; Elwood PC; Antony AC; Kolhouse JF
J Biol Chem; 1986 Jan; 261(1):44-9. PubMed ID: 3941083
[TBL] [Abstract][Full Text] [Related]
20. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
